Key result
Patients with early-phase ARVC had lower right ventricular ejection fraction (41% vs 49%, P<0.001), increased basal diameter, and pronounced mechanical dispersion compared with RVOT-VT patients.
Why the study?
Can ECG and cardiac imaging parameters help discriminate early-phase ARVC from RVOT-VT?
Observational (n=165)
Can ECG and cardiac imaging parameters help discriminate early-phase ARVC from RVOT-VT?
Absolute Event Rate: 41% vs 49%
p-value: p=<0.001
Structural abnormalities including lower RV ejection fraction, increased RV basal diameter, and pronounced RV mechanical dispersion, along with lower PVC burden, can help differentiate early-phase ARVC from RVOT-VT.
May aid echocardiographic differentiation of early ARVC from RVOT-VT; leaves open prospective validation before clinical adoption.
AIMS: Differentiation between early-phase arrhythmogenic right ventricular cardiomyopathy (ARVC) and right ventricular outflow tract (RVOT)-ventricular tachycardia (VT) can be challenging, and correct diagnosis is important. We compared electrocardiogram (ECG) parameters and morphological right ventricular (RV) abnormalities and investigated if ECG and cardiac imaging can help to discriminate early-phase ARVC from RVOT-VT patients. METHODS AND RESULTS: We included 44 consecutive RVOT-VT (47 ± 14 years) and 121 ARVC patients (42 ± 17 years). Of the ARVC patients, 77 had definite ARVC and 44 had early-phase ARVC disease. All underwent clinical examination, ECG, and Holter monitoring. Frequency of premature ventricular complexes (PVC) was expressed as percent per total beats/24 h (%PVC), and PVC configuration was recorded. By echocardiography, we assessed indexed RV basal diameter (RVD), indexed RVOT diameter, and RV and left ventricular (LV) function. RV mechanical dispersion (RVMD), reflecting RV contraction heterogeneity, was assessed by speckle-tracking strain echocardiography. RV ejection fraction (RVEF) was assessed by cardiac magnetic resonance imaging (CMR). Patients with early-phase ARVC had lower %PVC by Holter and PVC more frequently originated from the RV lateral free wall (both P < 0.001). RVD was larger (21 ± 3 vs. 19 ± 2 mm, P < 0.01), RVMD was more pronounced (22 ± 15 vs. 15 ± 13 ms, P = 0.03), and RVEF by CMR was decreased (41 ± 8 vs. 49 ± 4%, P < 0.001) in early-phase ARVC vs. RVOT-VT patients. CONCLUSION: Patients with early-phase ARVC had structural abnormalities with lower RVEF, increased RVD, and pronounced RVMD in addition to lower %PVC by Holter compared with RVOT-VT patients. These parameters can help correct diagnosis in patients with unclear phenotypes.
No takes yet. Share an insight, caveat, or question.
Saberniak et al. (2016) conducted an observational in Early-phase arrhythmogenic right ventricular cardiomyopathy (ARVC) and right ventricular outflow tract ventricular tachycardia (RVOT-VT) (n=165). Early-phase ARVC vs. RVOT-VT was evaluated on Right ventricular ejection fraction (RVEF) assessed by cardiac magnetic resonance imaging (p=<0.001). Patients with early-phase ARVC had lower right ventricular ejection fraction (41% vs 49%, P<0.001), increased basal diameter, and pronounced mechanical dispersion compared with RVOT-VT patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: